Thank you for the question.
I would say that, again, being responsible for procurement, I wouldn't really be able to speak to the policy and the outcomes with respect to the opioid crisis. What I can assure Canadians is that with our new office of supplier integrity and compliance, we are analyzing companies. We're looking for instances in which companies have maybe defrauded governments or in which they have been involved in corruption and collusion, and we're making sure we're not doing business with those entities.
With respect to the NMSO and the work that was done, I would note that the work was done by McKinsey & Company Canada and was very focused on benchmarking, transformation, IT and procurement—and not on health advice.